Avraham Hampel
Corporate Officer/Principal presso OPHECTRA REAL ESTATE AND INVESTMENTS LTD
Profilo
Avraham Hampel is currently the Secretary at BioCancell Therapeutics, Inc. and the Vice President-Corporate Development at Steakholder Foods Ltd.
He previously worked as a Secretary at Anchiano Therapeutics Ltd.
Posizioni attive di Avraham Hampel
| Società | Posizione | Inizio |
|---|---|---|
| OPHECTRA REAL ESTATE AND INVESTMENTS LTD | Corporate Officer/Principal | 01/09/2020 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Segretario Aziendale | 14/08/2009 |
Precedenti posizioni note di Avraham Hampel
| Società | Posizione | Fine |
|---|---|---|
| ANCHIANO THERAPEUTICS LTD. | Segretario Aziendale | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OPHECTRA REAL ESTATE AND INVESTMENTS LTD | Consumer Non-Durables |
| Aziende private | 2 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
- Borsa valori
- Insiders
- Avraham Hampel